Farcast Biosciences
24,000 human tumors and counting - building the most precise functional precision tumor microdynamics platform
Bengaluru, India
38 employees
Pre Seed
Total: $74.63M
Biotechnology, Health Care +1
General Information
Get notified when Farcast Biosciences moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Farcast Biosciences
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
India Market
Biotechnology
About Farcast Biosciences
Taxonomy: tumor microdynamics platform, clinical diagnostics, cancer treatment, oncology, translational biology, preclinical drug testing, oncolytic virus, immuno-oncology, monoclonal antibodies, bispecifics, tumor microenvironment, biopharmaceutical research
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | •••••• | 1 |
|
15 Jul 2019 |
| Series C | •••••• | 5 |
|
12 Jul 2018 |
| Series B | •••••• | 4 |
|
29 Aug 2016 |
| Series B | •••••• | 1 |
|
24 Oct 2013 |
| Grant | •••••• | - | 01 Jan 2012 |
Farcast Biosciences Alternatives & Competitors
It’s about time we think smarter and faster than cancer.
Developing Isunakinra - a potent IL-1 inhibitor - as an Immuno-Oncology agent
MOTO-CAR®s: Innovative macrophage technology designed to provide effective treatment for patients wi...
EV Therapeutics
Elephas
FAQ About Farcast Biosciences
Don't just browse. Track.
Signal Tracker monitors Farcast Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.